We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

105 hedge funds and large institutions have $653M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 8

48% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 27

22% more capital invested

Capital invested by funds: $535M → $653M (+$118M)

21% more funds holding

Funds holding: 87 → 105 (+18)

17% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $880K

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
105
Holders Change
+18
Holders Change %
+20.69%
% of All Funds
3.03%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
28
Increased
40
Reduced
27
Closed
8
Calls
$1.03M
Puts
$880K
Net Calls
+$146K
Net Calls Change
+$73K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$23.8M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$22.1M
3
BBA
Baker Bros. Advisors
New York
+$11.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.06M
5
State Street
State Street
Massachusetts
+$7.72M

Top Sellers

Rank Fund Capital Flow
1
RCP
Rho Capital Partners
New York
-$58.2M
2
SCA
SAC Capital Advisors
Connecticut
-$10.2M
3
BC
Broadfin Capital
New York
-$10M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.98M
5
KCM
Kingdon Capital Management
New York
-$8.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
PointState Capital
New York
$5.78M +$5.6M +288,959 New
Invesco
27
Invesco
Georgia
$5.49M +$2.31M +119,013 +77%
GP
28
GLG Partners
United Kingdom
$5.4M +$5.24M +270,000 New
Axa
29
Axa
France
$4.97M +$1.55M +80,166 +48%
Deutsche Bank
30
Deutsche Bank
Germany
$3.77M +$546K +28,135 +18%
ICRM
31
Insight Capital Research & Management
California
$3.76M -$125K -6,452 -3%
U
32
UBS
Switzerland
$3.38M -$146K -7,521 -4%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$3.25M +$54.4K +2,807 +2%
EI
34
EAM Investors
California
$2.95M -$715K -36,876 -20%
MAA
35
Managed Account Advisors
New Jersey
$2.86M +$2.77M +142,724 New
MSA
36
Mason Street Advisors
Wisconsin
$2.69M – – –
TC
37
TFS Capital
Pennsylvania
$2.65M +$2.56M +132,205 New
TCIM
38
TIAA CREF Investment Management
New York
$1.94M – – –
CS
39
Credit Suisse
Switzerland
$1.92M +$109K +5,646 +6%
ACM
40
Atika Capital Management
New York
$1.86M +$696K +35,900 +63%
PI
41
Putnam Investments
Massachusetts
$1.62M +$1.57M +80,900 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$1.57M +$112K +5,764 +8%
RFC
43
Russell Frank Company
Washington
$1.55M -$264K -13,625 -13%
WMSA
44
Weiss Multi-Strategy Advisers
New York
$1.42M +$212K +10,930 +18%
BIM
45
BlackRock Investment Management
Delaware
$1.41M +$13K +672 +1%
OAM
46
Oxford Asset Management
United Kingdom
$1.36M +$1.32M +68,109 New
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
$1.34M +$1.3M +66,909 New
USAA
48
United Services Automobile Association
Texas
$1.33M -$319K -16,467 -20%
Ameriprise
49
Ameriprise
Minnesota
$1.25M -$366K -18,869 -23%
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.23M +$242K +12,500 +25%
1
2
3 4 5

ANAC Hedge Fund Activity: Q1 2014 in Review

105 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q1 2014, worth a combined $653M — up 22% from $535M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ANAC positions and 8 closed out — a net gain of 20 holders — while 40 added to existing stakes and 27 trimmed.

The largest buyer was Eagle Asset Management, opening a new position worth an estimated $23.8M. The largest seller was Rho Capital Partners, cutting an estimated $58.2M.

  • 105 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q1 2014, up from 87 in Q4 2013.
  • Funds reported $653M of ANACOR PHARMACEUTICALS INC COM stock for Q1 2014, up 22% quarter-over-quarter.
  • 28 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q1 2014 and 8 closed out, a net change of +20 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q1 2014 was Eagle Asset Management, an estimated $23.8M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q1 2014 was Rho Capital Partners, an estimated $58.2M sold.

Based on aggregated 13F filings for Q1 2014.